FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting approval of the generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Osteoarthritis

Drugs mentioned

• Duloxetine delayed-release (Duloxetine hydrochloride)

Snippet

SUPPL AP for DULOXETINE DELAYED-RELEASE (DULOXETINE HYDROCHLORIDE)